Insights into the cholecystokinin 2 receptor binding site and processes of activation

Molecular Pharmacology

Volumn 70, Issue 6, 2006, Pages 1935-1945

  Paillasse, Michaël R ^b   Deraeve, Céline ^a   De Medina, Philippe ^b   Mhamdi, Loubna ^a   Favre, Gilles ^a   Poirot, Marc ^a   Silvente Poirot, Sandrine ^a,b  

^a INSERM   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ 2; CHOLECYSTOKININ B RECEPTOR; GLUTAMIC ACID; HISTIDINE; INOSITOL PHOSPHATE; PHENYLALANINE; SERINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SULFATION;

ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; RECEPTOR, CHOLECYSTOKININ B; TRYPTOPHAN;

EID: 33751075492     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029967     Document Type: Article

References (37)

1. 2 receptor. Mol Pharmacol 57:890-898.
2. Aly A, Shulkes A, and Baldwin GS (2004) Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta 1704:1-10.
3. Arnis S, Fahmy K, Hofmann KP, and Sakmar TP (1994) A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J Biol Chem 269:23879-23881.
4. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen SG, Shi L, Gether U, and Javitch JA (2001) Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276:29171-29177.
5. Ballesteros JA and Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366-428.
6. Beinborn M, Quinn SM, and Kopin AS (1998) Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties. J Biol Chem 273:14146-14151.
7. Blaker M, Ren Y, Gordon MC, Hsu JE, Beinborn M, and Kopin AS (1998) Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists. Mol Pharmacol 54:857-863.
8. Borhan B, Souto ML, Imai H, Shichida Y, and Nakanishi K (2000) Movement of retinal along the visual transduction path. Science (Wash DC) 288:2209-2212.
9. Cohen GB, Yang T, Robinson PR, and Oprian DD (1993) Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 32:6111-6115.
10. Cotecchia S, Fanelli F, and Costa T (2003) Constitutively active G protein-coupled receptor mutants: implications on receptor function and drug action. Assay Drug Dev Technol 1:311-316.
11. Creighton TE (1993) Protein, Structure and Molecular Properties. W.H. Freeman and Company, New York.
12. de Tullio P, Delarge J, and Pirotte B (2000) Therapeutic and chemical developments of cholecystokinin receptor ligands. Expert Opin Investig Drugs 9:129-146.
13. Ding WQ, Kuntz SM, and Miller LJ (2002) A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3′-splicing site leading to retention of the fourth intron. Cancer Res 62:947-952.
14. Doi T, Molday RS, and Khorana HG (1990) Role of the intradiscal domain in rhodopsin assembly and function. Proc Natl Acad Sci USA 87:4991-4995.
15. Fanelli F and De Benedetti PG (2005) Computational modeling approaches to structure-function analysis of G protein-coupled receptors. Chem Rev 105:3297-3351.
16. q protein activation without affecting its association with the receptor. J Biol Chem 275:17321-17327.
17. Gales C, Poirot M, Taillefer J, Maigret B, Martinez J, Moroder L, Escrieut C, Pradayrol L, Fourmy D, and Silvente-Poirot S (2003a) Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. Mol Pharmacol 63:973-982.
18. Gales C, Sanchez D, Poirot M, Pyronnet S, Buscail L, Cussac D, Pradayrol L, Fourmy D, and Silvente-Poirot S (2003b) High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. Oncogene 22:6081-6089.
19. Gether U (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113.
20. Harris JC, Clarke PA, Awan A, Jankowski J, and Watson SA (2004) An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus. Cancer Res 64:1915-1919.
21. Hellmich MR, Rui XL, Hellmich HL, Fleming RY, Evers BM, and Townsend CM Jr (2000) Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J Biol Chem 275:32122-32128.
22. Javitch JA, Shi L, Simpson MM, Chen J, Chiappa V, Visiers I, Weinstein H, and Ballesteros JA (2000) The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. Biochemistry 39:12190-12199.
23. McGaughey GB, Gagne M, and Rappe AK (1998) pi-Stacking interactions. Alive and well in proteins. J Biol Chem 273:15458-15463.
24. Munson PJ and Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
25. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, and Clauser E (2002) Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13:336-343.
26. Rasmussen SG, Jensen AD, Liapakis G, Ghanouni P, Javitch JA, and Gether U (1999) Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 56:175-184.
27. Ren Y, Blaker M, Seshadri L, McBride EW, Beinborn M, and Kopin AS (2003) Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity. J Mol Neurosci 20:115-124.
28. Reubi JC, Schaer JC, and Waser B (1997) Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377-1386.
29. Rozengurt E and Walsh JH (2001) Gastrin, CCK, signaling, and cancer. Annu Rev Physiol 63:49-76.
30. Scheer A, Fanelli F, Costa T, De Benedetti PG, and Cotecchia S (1997) The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813.
31. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, and Elling CE (2006) Molecular mechanism of 7TM receptor activation - a global toggle switch model. Annu Rev Pharmacol Toxicol 46:481-519.
32. Shi L and Javitch JA (2002) The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42:437-467.
33. Shi L and Javitch JA (2004) The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci USA 101:440-445.
34. Silvente-Poirot S, Escrieut C, Gales C, Fehrentz JA, Escherich A, Wank SA, Martinez J, Moroder L, Maigret B, Bouisson M, et al. (1999) Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. J Biol Chem 274:23191-23197.
35. Silvente-Poirot S, Escrieut C, and Wank SA (1998) Role of the extracellular domains of the cholecystokinin receptor in agonist binding. Mol Pharmacol 54:364-371.
36. Silvente-Poirot S and Wank SA (1996) A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin. J Biol Chem 271:14698-14706.
37. Wank SA (1995) Cholecystokinin receptors. Am J Physiol 269:G628-G646.